About

Make Your Impact

Be a part of our vision!

The RTICC aims to create an inclusive and collaborative environment, which is essential for transforming scientific discoveries into life-changing reality. Your support can help to establish cutting-edge technology and infrastructure, support our young scientists, and accelerate the pace of discovery!
Research is our strongest weapon in the fight against cancer, and the Technion’s continued success in this endeavor is largely measured by the support it receives from our loyal friends around the globe. We present you with an opportunity to partner with our globally renowned scientists as they continue to navigate the complexities of cancer, discovering transformative treatment pathways with true potential to curb the staggering rate and prevalence of this complex collection of diseases.
Your support will fuel the research efforts of more than 80 principal investigators from 11 Technion faculties and five of the Technion’s affiliated hospitals, in both basic research as well as in the translational and clinical aspects of cancer research.

You can help us push the boundaries of research, fuel discovery, and reimagine the future of cancer care

FACULTY RECRUITMENT INITIATIVES

The single most important asset of the Bruce and Ruth Rappaport Cancer Research Center is its faculty members, who form the backbone of the Technion and its world-class research. Attracting the brightest minds in science and engineering is what ultimately advances the Technion’s global reputation as a leader in education and research. Technion leadership continues to prioritize the recruitment of faculty members who are at the forefront of scientific discovery.

Support of faculty recruitment will enable the Center to offer generous startup packages to faculty members of the highest caliber who form the very foundation that transformative cancer research is built upon. Your support will have a direct impact on the Technion’s ability to make extraordinary contributions to cancer research, both today and well into the future.

Top: Drug Delivery-All rights reserved to Prof. Yoav Livney, Faculty of Biotechnology and Food Engineering, Technion- Israel Institute of Technology
Top: Drug Delivery-All rights reserved to Prof. Yoav Livney, Faculty of Biotechnology and Food Engineering, Technion- Israel Institute of Technology
Bottom: Prof. Avi Schroeder Lab, Faculty of Chemical Engineering, Technion-Israel Institute of Technology

ACADEMIC AND RESEARCH SUPPORT

Top: Prof. Amir Orian Lab, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology Bottom: Accumulation of nanoparticles in neuron cell culture (nanoparticles are red, cell nuclei are blue). All rights reserved to Prof. Avi Schroeder, Faculty of Chemical Engineering, Technion‒Israel Institute of Technology.
Top: Prof. Amir Orian Lab, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology
Bottom: Accumulation of nanoparticles in neuron cell culture (nanoparticles are red, cell nuclei are blue). All rights reserved to Prof. Avi Schroeder, Faculty of Chemical Engineering, Technion‒Israel Institute of Technology.

The RTICC offers unique cancer training opportunities to both PhD and postdoctoral researchers. The Center’s leadership believes that the next generation of cancer researchers must be trained in multiple disciplines and strive to cultivate a broad spectrum of knowledge.

To facilitate this objective, the Center has established a joint PhD and postdoctoral training program that will provide young researchers with the opportunity to conduct cancer-focused interdisciplinary research projects under the supervision of two mentors from various fields of cancer research.

EXPANDING AND EQUIPPING CANCER RESEARCH FACILITIES

Top-level facilities are indispensable for cancer research, providing state-of-the-art equipment, cutting-edge technologies, and optimal infrastructure to create an environment where innovative experiments can flourish.

The new D. Dan and Betty Kahn Human Health Building will be the future home of the Center. With an expected completion date of early 2027, the new five-story building will span more than 150,800 sq. ft. and will include expansive laboratory space as well as a 200-seat auditorium for lectures and seminars. Each of the research laboratory floors will cover approximately 13,000 sq. ft. A typical laboratory floor will also provide offices for researchers and administrative staff, a meeting room, restrooms, storage rooms, and maintenance rooms.

Your support will enable the Technion to accelerate the pace of innovation and discovery by breaking free from the conventional lab arrangements of the past. Your contributions will support the capital needs of the D. Dan and Betty Kahn Human Health Building and directly enable researchers to carry out all stages of experimentation, including design, execution, and data analysis.

Bottom: BCF, Technion- Israel Institute of Technology
Bottom: BCF, Technion- Israel Institute of Technology

Support Our Science

You can contribute to the RTICC by giving to a broad range of gift opportunities

We deeply thank you for your support!